Cote d'Ivoire vs Uganda: Population requiring preventive chemotherapy for schistosomiasis
Cote d'Ivoire
8.30 million
in 2024
Uganda
7.98 million
in 2024
Cote d'Ivoire rank
10th
Uganda rank
11th
Population requiring preventive chemotherapy for schistosomiasis over time
- Cote d'Ivoire
- Uganda
How they compare
Cote d'Ivoire currently reports 8.30 million against 7.98 million in Uganda, a difference of 321,570.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Uganda ahead.
Cote d'Ivoire ranks 10th and Uganda ranks 11th of 52 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.22 million | 10.07 million | 5.85 million | Uganda |
| 2020s | 6.94 million | 9.71 million | 2.77 million | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Cote d'Ivoire or Uganda?
- Cote d'Ivoire, at 8.30 million against 7.98 million in Uganda as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Cote d'Ivoire and Uganda?
- 321,570, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Uganda?
- 15 years are reported by both, from 2010 to 2024.
- How do Cote d'Ivoire and Uganda rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Cote d'Ivoire ranks 10th and Uganda ranks 11th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.